Dr Yae-eun Suh
MBChB BSc (Med Sci) MSc MRCP FRCP PhD
Languages spoken
English
Overview
Dr Yae-eun Suh is a Consultant Clinical Oncologist specialising in radiotherapy and systemic treatments for prostate cancer. She was appointed as a Consultant at the Royal Marsden NHS Foundation Trust in 2016 and has been a Uro-Oncology specialist advisor and MRL specialist for GenesisCare since 2023.
She qualified from the University of Edinburgh and undertook her specialist training in Clinical Oncology at The Royal Sussex County Hospital, Guy’s and St Thomas’ Hospital and The Royal Marsden. Dr Suh was awarded a PhD from King’s College London in 2016. Her doctoral research investigated the integration of imaging and molecular biomarkers to identify radioresistance, as well as the use of functional imaging to guide radiotherapy dose escalation to overcome treatment resistance.
Her clinical expertise spans the full spectrum of prostate cancer, including localised, recurrent and advanced disease. She specialises in advanced radiotherapy techniques such as stereotactic body radiotherapy (SABR/SBRT), focal boost strategies, metastasis-directed therapy and salvage radiotherapy following surgery.
Her research interests include technical radiotherapy, integration of systemic therapies with radiotherapy, and improving patient quality of life.
"I specialise in prostate cancer and focus on delivering precise, evidence-based radiotherapy and systemic treatment. My role is to assess each case carefully and recommend a personalised treatment strategy grounded in current clinical evidence and guidelines. I see optimal management as a shared, informed decision-making process. I aim to ensure you have straightforward communication and continuity of care throughout treatment.
If you choose to be cared for by me, you can expect clear recommendations, technical expertise and a collaborative approach focused on achieving optimal cancer control whilst maintaining quality of life."
Dr Yae-eun Suh
- Localised, recurrent and advanced prostate cancer
- Stereotactic body radiotherapy (SABR/SBRT)
- Focal boost strategies
- Metastasis-directed therapy
- Salvage radiotherapy following surgery
- Technical radiotherapy
- Integration of systemic therapies with radiotherapy
- GMC (Registration number 6048669)
- RCR
Access my publications here